Schedule 13D ownership disclosure
IMMUCELL CORP /DE/
Common Stock · CUSIP: 452525306
Event date: 2024-05-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- SRK FUND I, LPReported CIK 0001744329
Shares: 391,322.00 · Class: 5.0%
- SRK Capital, LLC
Shares: 391,322.00 · Class: 5.0%
- Sean Kirkwood
Shares: 391,322.00 · Class: 5.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001744329-24-000003
- Form type
- SCHEDULE 13D
- Filer
- IMMUCELL CORP /DE/
- CIK
- CIK 811641
- Filed
- May 22, 2024
- Reporting period
- May 22, 2024
- Description
- Schedule 13D beneficial ownership